• Identification and Characterization of Cancer Stem-Like Cells in ALK-Positive Anaplastic Large Cell Lymphoma Using the SORE6 Reporter (vol 43, pg 543, 2021)

• Identification and Characterization of HD1, a Novel Ofloxacin-Degrading Bacillus Strain

• Identification of risk and prognostic factors for intrahepatic vascular invasion in patients with hepatocellular carcinoma: a population-based study

• Identification and Analysis of Potential Immune-Related Biomarkers in Endometriosis

• Identification of comutation in signaling pathways to predict the clinical outcomes of immunotherapy

• Identification of cross-reactive CD8+ T cell receptors with high functional avidity to a SARS-CoV-2 immunodominant epitope and its natural mutant variants

• Identifying spatial relations of industrial carbon emissions among provinces of China: evidence from unsupervised clustering algorithms

• Identification of the seismoelectric field induced by a slow compressional wave at an ultrasonic frequency

• Identification of a cellular senescence-related-lncRNA (SRlncRNA) signature to predict the overall survival of glioma patients and the tumor immune microenvironment

• Identifying patients with acute ischemic stroke within a 6-h window for the treatment of endovascular thrombectomy using deep learning and perfusion imaging

• Identification and validation of hub genes and potential drugs involved in osteoarthritis through bioinformatics analysis

• Identification of region-specific amino acid signatures for doxorubicin-induced chemo brain

• Identification of heel bone mineral density as a risk factor of Alzheimer's disease by analyzing large-scale genome-wide association studies datasets

• Identification of MIR600HG/hsa-miR-342-3p/ANLN network as a potential prognosis biomarker associated with lmmune infiltrates in pancreatic cancer

• Identification and validation of feature genes associated with M1 macrophages in preeclampsia

• Identification of PANoptosis-relevant subgroups to evaluate the prognosis and immune landscape of patients with liver hepatocellular carcinoma

• Identification of an Epigenetic Signature for Coronary Heart Disease in Postmenopausal Women's PBMC DNA

• Identification of microRNAs related with neural germ layer lineage-specific progenitors during reprogramming

• Identification and validation of a necroptosis-related gene prognostic signature for colon adenocarcinoma

• Identification of immunotherapy biomarkers for improving the clinical outcome of homologous recombination deficiency patients with lung adenocarcinoma

• Identification of Prognostic Biomarkers for Glioblastoma Based on Transcriptome and Proteome Association Analysis

• Identification of Enhancer RNA CDK6-AS1 as a Potential Novel Prognostic Biomarker in Gastric Cancer

• Identification and Validation in a Novel Quantification System of Ferroptosis Patterns for the Prediction of Prognosis and Immunotherapy Response in Left- and Right-Sided Colon Cancer

• Identification of Prognostic Biomarkers for Bladder Cancer Based on DNA Methylation Profile

• Identifying immune checkpoint-related lncRNA biomarkers for immunotherapy response and prognosis in cancers

• Identification of key genes and therapeutic drugs for cocaine addiction using integrated bioinformatics analysis

• Identification of differentially expressed miRNAs and key genes involved in the progression of alcoholic fatty liver disease using rat models

• Identification of lactylation related model to predict prognostic, tumor infiltrating immunocytes and response of immunotherapy in gastric cancer

• Identifying tumour microenvironment-related signature that correlates with prognosis and immunotherapy response in breast cancer

• Identification and validation of DNA methylation-driven gene PCDHB4 as a novel tumor suppressor for glioblastoma diagnosis and prognosis

• Identification of PYGL as a key prognostic gene of glioma by integrated bioinformatics analysis

• Identification of Prognostic Gene Signatures by Developing a scRNA-Seq-Based Integration Approach to Predict Recurrence and Chemotherapy Benefit in Stage II-III Colorectal Cancer

• Identification of afatinib-associated ADH1B and potential small-molecule drugs targeting ADH1B for hepatocellular carcinoma

• Identification of immune characteristic landscapes related to autophagy in ischemic stroke

• Identification of hub genes in chronic pancreatitis and analysis of association with pancreatic cancer via bioinformatic analysis

• Identification of circulating immune landscape in ischemic stroke based on bioinformatics methods

• Identification of the Crucial Role of CCL22 in F. nucleatum-Related Colorectal Tumorigenesis that Correlates With Tumor Microenvironment and Immune Checkpoint Therapy